25.57 USD
↗ 0.84 (3.40%)AT CLOSE (11:59 AM EDT)
Denali Therapeutics Inc. Common Stock
DNLINASDAQ • USD
25.34
↘ 0.24 (0.92%)
POST MARKET (AS OF 07:10 PM EDT)
Post Market
AS OF 07:10 PM EDT
25.34
↘ 0.24 (0.92%)
Market: CLOSED
DNLI is currently priced at $25.57. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. DNLI is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$24.78
High?$25.70
Low?$24.65
Prev. Close?$24.73
Volume?6.5M
Avg. Volume?2.0M
VWAP?$25.11
Rel. Volume?3.23x
Bid / Ask
Bid?$21.74 × 100
Ask?$28.92 × 100
Spread?$7.18
Midpoint?$25.33
Valuation & Ratios
Market Cap?4.1B
Shares Out?158.7M
Float?128.2M
Float %?87.4%
P/E Ratio?N/A
P/B Ratio?4.38
EPS?-$3.21
Dividend?0.00%
Ex-Dividend?N/A
RelatedBEAM
News
Profile
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Employees
507
Market Cap
3.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-12-08
Address
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 866-8547
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 866-8547
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?94
Momentum?65
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?4.19Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?12.02%High
Short Interest?15.4M
Days to Cover?8.4
Free Float128.2M
Avg Daily Volume1.8M
Settlement Date2026-06-15
Financial Health
Current Ratio?9.28Strong
Quick Ratio?9.28Strong
Cash Ratio?3.52Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.38FAIR▾
Peers50
S&P41
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-55.0%WEAK▾
S&P3
ROA?-40.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-419226000
Enterprise Value?$3.7B
Fundamentals ratios updated end of day